tranexamic acid has been researched along with Parkinson Disease, Secondary in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rotenone is a pesticide that has been shown to induce the pathological symptoms of Parkinson's disease (PD) in animal models." | 5.35 | Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. ( Chung, JH; Kim, HJ; Park, HJ; Park, HK, 2009) |
| "Rotenone is a pesticide that has been shown to induce the pathological symptoms of Parkinson's disease (PD) in animal models." | 1.35 | Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. ( Chung, JH; Kim, HJ; Park, HJ; Park, HK, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, HJ | 1 |
| Park, HJ | 1 |
| Park, HK | 1 |
| Chung, JH | 1 |
1 other study available for tranexamic acid and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Tranexamic acid protects against rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells.
Topics: Antifibrinolytic Agents; Apoptosis; bcl-2-Associated X Protein; Caspases; Cell Line, Tumor; Cell Sur | 2009 |